Contributing Editor, Pharmaceutical PAT

Marcus Whitfield

Boston, USA

Marcus covers process analytical technology in pharmaceutical and biopharmaceutical manufacturing for Spectrane. His reporting focuses on regulatory developments, continuous manufacturing adoption, and the tools and people behind real-time release. He has spent the better part of two decades adjacent to pharmaceutical process engineering on the U.S. East Coast.

Articles by Marcus Whitfield

news

Continuous manufacturing in pharma: a status report through early 2026

Twenty years after the first FDA continuous manufacturing approval, the technology is no longer experimental — but adoption is uneven, and the bottlenecks are now organizational, not technical.

Marcus Whitfield May 8, 2026

interview

Field notes: what scaling PAT across multiple plants actually involves

A composite of conversations with engineers running multi-site PAT programs. The technical work is straightforward; the parts that go wrong are organizational, contractual, and cultural.

Marcus Whitfield Apr 25, 2026